Sunday , April 23 2017
Home / Treatments and Medicines

Treatments and Medicines

Breaking news: FDA Approves The First Drug for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis

FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis U.S. Commercial Launch Planned for June 2016 The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the …

Read More »

Doctors test new Parkinson treatment

University of Pittsburgh School of Medicine researchers are leading the second arm of a trial, now recruiting participants, that will use gene therapy to assist in the easing of tremors and mobility symptoms in Parkinson’s disease patients. The therapy’s goal is to prolong the efficacy of levodopa, a drug used …

Read More »